Suchergebnisse - "Bitzer, Michael"

PubPharm (302)

1

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Sangro, B. | Chan, S. | Kelley, R. | +123

2

enthalten in: Zeitschrift fur Gastroenterologie | 2024

von Bitzer, M. | Groß, S. | Albert, J. | +64

3

enthalten in: Zeitschrift fur Gastroenterologie | 2024

von Groß, S. | Bitzer, M. | Albert, J. | +64

4

The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma

enthalten in: Nature communications | 2024

von Spahn, S. | Kleinhenz, F. | Shevchenko, E. | +16

5

Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations

enthalten in: Cancer research and treatment | 2024

von Lindley, A. | Prager, G. | Bitzer, M. | +3

6

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Tandler, C. | Heitmann, J. | Michel, T. | +18

7

enthalten in: Zeitschrift fur Gastroenterologie | 2024

von Bitzer, M. | Groß, S. | Albert, J. | +64

8

enthalten in: Zeitschrift fur Gastroenterologie | 2024

von Groß, S. | Bitzer, M. | Blödt, S. | +9

9

enthalten in: Zeitschrift fur Gastroenterologie | 2024

von Groß, S. | Bitzer, M. | Albert, J. | +64

10

FusionVAC22_01 : a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion

enthalten in: Frontiers in oncology | 2024

von Hackenbruch, C. | Bauer, J. | Heitmann, J. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]